FibroBiologics, Inc. Common Stock (FBLG) — Net Asset Momentum
FibroBiologics, Inc. Common Stock (FBLG) recorded a net asset momentum of 118.3% as of June 2025, with net assets of $2.73 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see market cap of FibroBiologics, Inc. Common Stock.
YoY Momentum
Current Net Assets
Years of Data
Country
FibroBiologics, Inc. Common Stock Net Asset Momentum (2022–2025)
This chart tracks FibroBiologics, Inc. Common Stock's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +118.3%, with net assets of $2.73 Million USD as of June 2025. See FBLG net asset quality score to measure how much of total assets are equity-financed.
Annual Net Asset History for FibroBiologics, Inc. Common Stock (2022–2025)
The table below shows the complete annual net asset history for FibroBiologics, Inc. Common Stock from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check FBLG intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $2.73 Million | $16.45 Million | $13.71 Million | ▲ +118.3% |
| 2024 | $1.25 Million | $11.82 Million | $10.57 Million | ▲ +131.4% |
| 2023 | $-4.00 Million | $4.82 Million | $8.82 Million | ▼ -209.8% |
| 2022 | $-1.29 Million | $468.00K | $1.76 Million | — |